Can a targeted drug keep working after cancer progresses? new trial aims to find out
NCT ID NCT07389265
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 trial tests whether continuing cetuximab (a targeted antibody) with chemotherapy after first-line treatment stops working can improve outcomes in metastatic colorectal cancer. About 480 adults whose tumors have specific genetic markers (RAS and BRAF wild-type) will receive either cetuximab plus chemo or bevacizumab plus chemo. The study measures tumor response, survival, and safety, with regular scans and blood tests.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cetuximab (Erbitux) combined with chemotherapy
- What this could lead to
- If successful, this could show that continuing cetuximab beyond initial progression helps control metastatic colorectal cancer better than switching to a different drug.
- What could go wrong
- This is a Phase 3 trial, but results may not confirm a benefit. The treatment involves chemotherapy side effects and requires ongoing medication, not a cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (MCRC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.O. 'Pia Fondazione Cardinale G.Panico'
NOT_YET_RECRUITINGTricase, Italy
-
A.O.U. Careggi
NOT_YET_RECRUITINGFlorence, Italy
-
A.O.U. Federico II
NOT_YET_RECRUITINGNaples, Italy
-
A.O.U. Ospedali Riuniti
NOT_YET_RECRUITINGAncona, Italy
-
A.O.U. Pisana
NOT_YET_RECRUITINGPisa, Italy
-
A.O.U. Sassari
NOT_YET_RECRUITINGSassari, Italy
-
A.O.U. dell'Università degli studi della Campania 'Luigi Vanvitelli'
RECRUITINGNaples, Italy
-
AORN S. Giuseppe Moscati
NOT_YET_RECRUITINGAvellino, Italy
-
ARNAS Civico - Di Cristina-Benfratelli - P. O. 'Civico e Benfratelli'
NOT_YET_RECRUITINGPalermo, Italy
-
ASST Grande Ospedale Metropolitano Niguarda
NOT_YET_RECRUITINGMilan, Italy
-
Azienda Ospedaliero-Universitaria Renato Dulbecco
NOT_YET_RECRUITINGCatanzaro, Italy
-
Azienda USL IRCCS di Reggio Emilia
NOT_YET_RECRUITINGReggio Emilia, Italy
-
Casa di Cura Villa Maria
NOT_YET_RECRUITINGMirabella Eclano, Italy
-
Casa di cura Macchiarella
NOT_YET_RECRUITINGPalermo, Italy
-
Centro di Riferimento Oncologico (C.R.O.) IRCCS
NOT_YET_RECRUITINGAviano, Italy
-
Fondazione IRCCS Istituto Nazionale dei Tumori
NOT_YET_RECRUITINGMilan, Italy
-
Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza
NOT_YET_RECRUITINGSan Giovanni Rotondo, Italy
-
Fondazione Poliambulanza Istituto Ospedaliero
NOT_YET_RECRUITINGBrescia, Italy
-
Fondazione Policlinico Universitario 'Agostino Gemelli' IRCCS
NOT_YET_RECRUITINGRoma, Italy
-
Hospital General Universitario Santa Lucía
NOT_YET_RECRUITINGCartagena, Spain
-
Hospital Universitari Vall d´Hebron
NOT_YET_RECRUITINGBarcelona, Spain
-
Hospital Universitario 12 de Octubre
NOT_YET_RECRUITINGMadrid, Spain
-
Hospital Universitario Gregorio Marañón
NOT_YET_RECRUITINGMadrid, Spain
-
Hospital Universitario Marqués de Valdecilla
NOT_YET_RECRUITINGSantander, Spain
-
Hospital Universitario Regional de Málaga
NOT_YET_RECRUITINGMálaga, Spain
-
Hospital Universitario Reina Sofía
NOT_YET_RECRUITINGCórdoba, Spain
-
Hospital Universitario Virgen de las Nieves
NOT_YET_RECRUITINGGranada, Spain
-
Hospital Universitario de Navarra
NOT_YET_RECRUITINGPamplona, Spain
-
Hospital del Mar
NOT_YET_RECRUITINGBarcelona, Spain
-
IRCCS I.N.T. 'Fondazione G. Pascale'
NOT_YET_RECRUITINGNaples, Italy
-
IRCCS Istituto Tumori "Giovanni Paolo II"
NOT_YET_RECRUITINGBari, Italy
-
IRCCS Istituto clinico Humanitas
NOT_YET_RECRUITINGRozzano, Italy
-
IRCCS Ospedale Sacro Cuore Don Calabria
NOT_YET_RECRUITINGVeneto, Italy
-
Instituto Catalán de Oncología. Hospital Duran i Reynals
NOT_YET_RECRUITINGL'Hospitalet de Llobregat, Spain
-
Istituto Europeo di Oncologia
NOT_YET_RECRUITINGMilan, Italy
-
Istituto Oncologico Veneto IRCCS
NOT_YET_RECRUITINGPadova, Italy
-
Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori'
NOT_YET_RECRUITINGMeldola, Italy
-
Nome EnteA.R.N.A.S. Garibaldi - P.O. Garibaldi-Nesima
NOT_YET_RECRUITINGCatania, Italy
-
Ospedale IRCCS 'Saverio de Bellis'
NOT_YET_RECRUITINGCastellana Grotte, Italy
-
Ospedale San Giuseppe Moscati
NOT_YET_RECRUITINGStatte, Italy
-
P.O. 'Vito Fazzi'
NOT_YET_RECRUITINGLecce, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vitamin b derivative boost chemo for advanced colon cancer?
- Exercise may boost Well-Being in advanced colorectal cancer patients
- Real-World study tests fruquintinib for Tough-to-Treat colorectal cancer
- New pill combo aims to tackle Hard-to-Treat colorectal cancer
- Promising drug duo targets Hard-to-Treat HER2 cancers
- New drug combo aims to extend life in tough colorectal cancer